TNF-α-secreting monocytes are recruited into the brain of cholestatic mice

Hepatology

Volumn 43, Issue 1, 2006, Pages 154-162

  Kerfoot, Steven M ^a   D'Mello, Charlotte ^a   Nguyen, Henry ^a   Ajuebor, Maureen N ^a   Kubes, Paul ^a   Le, Tai ^a   Swain, Mark G ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN CORTEX; BRAIN METABOLISM; CELL INFILTRATION; CELL SECRETION; CHOLESTASIS; CONTROLLED STUDY; ENDOTHELIUM CELL; INFLAMMATORY CELL; MACROPHAGE; MALE; MICROSCOPY; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; BRAIN; C57BL MOUSE; CELL MOTION; DISEASE MODEL; FATIGUE; GENETICS; IMMUNOLOGY; LEUKOCYTE ROLLING; PATHOLOGY; PHYSIOLOGY; VASCULARIZATION;

ANIMALS; BRAIN; CELL MOVEMENT; CHOLESTASIS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FATIGUE; LEUKOCYTE ROLLING; MALE; MICE; MICE, INBRED C57BL; MONOCYTES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 33644791099     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21003     Document Type: Article

References (49)

1. Dantzer R. Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. Eur J Pharmacol 2004;500:399-411.
2. Swain MG. Fatigue in chronic disease. Clin Sci (Lond) 2000;99:1-8.
3. Kent S, Bluthe RM, Kelley KW, Dantzer R. Sickness behavior as a new target for drug development. Trends Pharmacol Sci 1992;13:24-28.
4. Jones EA. Fatigue complicating chronic liver disease. Metab Brain Dis 2004;19:421-429.
5. Huet PM, Deslauriers J, Tran A, Faucher C, Charbonneau J. Impact of fatigue on the quality of life of patients with primary biliary cirrhosis. Am J Gastroenterol 2000;95:760-767.
6. Cauch-Dudek K, Abbey S, Stewart DE, Heathcote EJ. Fatigue in primary biliary cirrhosis. Gut 1998;43:705-710.
7. Swain MG, Maric M. Improvement in cholestasis-associated fatigue with a serotonin receptor agonist using a novel rat model of fatigue assessment. HEPATOLOGY 1997;25:291-294.
8. Burak KW, Le T, Swain MG. Increased sensitivity to the locomotor-activating effects of corticotropin-releasing hormone in cholestatic rats. Gastroenterology 2002;122:681-688.
9. Swain MG. Cytokines and neuroendocrine dysregulation in obstructive cholestasis: pathophysiological implications. J Hepatol 2001;35:416-418.
10. Blatteis CM, Sehic E, Li S. Pyrogen sensing and signaling: old views and new concepts. Clin Infect Dis 2000;5(Suppl):168-177.
11. Adachi A. Projection of the hepatic vagal nerve in the medulla oblongata. J Auton Nerv Syst 1984;10:287-293.
12. Magni F, Carobi C. The afferent and preganglionic parasympathetic innervation of the rat liver, demonstrated by the retrograde transport of horseradish peroxidase. J Auton Nerv Syst 1983;8:237-260.
13. Goehler LE, Gaykema RP, Hansen MK, Anderson K, Maier SF, Watkins LR. Vagal immune-to-brain communication: a visceral chemosensory pathway. Auton Neurosci 2000;85:49-59.
14. Luheshi GN, Bluthe RM, Rushforth D, Mulcahy N, Konsman JP, Goldbach M, et al. Vagotomy attenuates the behavioural but not the pyrogenic effects of interleukin-1 in rats. Auton Neurosci 2000;85:127-132.
15. Turnbull AV, Rivier CL. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev 1999;79:1-71.
16. Licinio J, Wong ML. Pathways and mechanisms for cytokine signaling of the central nervous system. J Clin Invest 1997;100:2941-2947.
17. Vollmer-Conna U, Fazou C, Cameron B, Li H, Brennan C, Luck L, et al. Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychol Med 2004;34:1289-1297.
18. Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judmaier G, et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992;103:264-274.
19. Bemelmans MH, Gouma DJ, Greve JW, Buurman WA. Cytokines tumor necrosis factor and interleukin-6 in experimental biliary obstruction in mice. HEPATOLOGY 1992;15:1132-1136.
20. Yamamoto Y, Sezai S, Sakurabayashi S, Hirano M, Kamisaka K, Oka H. A study of endotoxaemia in patients with primary biliary cirrhosis. J Int Med Res 1994;22:95-99.
21. Clements WD, Erwin P, McCaigue MD, Halliday I, Barclay GR, Rowlands BJ. Conclusive evidence of endotoxaemia in biliary obstruction. Gut 1998;42:293-299.
22. Abe T, Arai T, Ogawa A, Hiromatsu T, Masuda A, Matsuguchi T, et al. Kupffer cell-derived interleukin 10 is responsible for impaired bacterial clearance in bile duct-ligated mice. HEPATOLOGY 2004;40:414-423.
23. Tontsch U, Bauer HC. Isolation, characterization, and long-term cultivation of porcine and murine cerebral capillary endothelial cells. Microvasc Res 1989;37:148-161.
24. Favre CJ, Mancuso M, Maas K, McLean JW, Baluk P, McDonald DM. Expression of genes involved in vascular development and angiogenesis in endothelial cells of adult lung. Am J Physiol Heart Circ Physiol 2003;285:H1917-H1938.
25. Wu Z, Hofman FM, Zlokovic BV. A simple method for isolation and characterization of mouse brain microvascular endothelial cells. J Neurosci Methods 2003;130:53-63.
26. Kerfoot SM, Kubes P. Overlapping roles of P-selectin and alpha 4 integrin to recruit leukocytes to the central nervous system in experimental autoimmune encephalomyelitis. J Immunol 2002;169:1000-1006.
27. Kerfoot SM, Long EM, Hickey MJ, Andonegui G, Lapointe BM, Zanardo RC, et al. TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease. J Immunol 2004;173:7070-7077.
28. Babcock AA, Kuziel WA, Rivest S, Owens T. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J Neurosci 2003;23:7922-7930.
29. Guillemin GJ, Brew BJ. Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J Leukoc Biol 2004;75:388-397.
30. Kerfoot SM, Raharjo E, Ho M, Kaur J, Serirom S, McCafferty DM, et al. Exclusive neutrophil recruitment with oncostatin M in a human system. Am J Pathol 2001;159:1531-1539.
31. Cook-Mills JM. VCAM-1 signals during lymphocyte migration: role of reactive oxygen species. Mol Immunol 2002;39:499-508.
32. Kubes P. The complexities of leukocyte recruitment. Semin Immunol 2002;14:65-72.
33. Joyce DA, Gimblett G, Steer JH. Targets of glucocorticoid action on TNF-alpha release by macrophages. Inflamm Res 2001;50:337-340.
34. Nadeau S, Rivest S. Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood-brain barrier. Neuroscience 1999;93:1449-1464.
35. Laflamme N, Rivest S. Effects of systemic immunogenic insults and circulating proinflammatory cytokines on the transcription of the inhibitory factor kappaB alpha within specific cellular populations of the rat brain. J Neurochem 1999;73:309-321.
36. Lacroix S, Rivest S. Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain. J Neurochem 1998;70:452-466.
37. Hickey WF. Basic principles of immunological surveillance of the normal central nervous system. Glia 2001;36:118-124.
38. Hickey WF. Leukocyte traffic in the central nervous system: the participants and their roles. Semin Immunol 1999;11:125-137.
39. Steffen BJ, Butcher EC, Engelhardt B. Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL/J mouse. Am J Pathol 1994;145:189-201.
40. Renno T, Krakowski M, Piccirillo C, Lin JY, Owens T. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. J Immunol 1995;154:944-953.
41. Carson MJ, Reilly CR, Sutcliffe JG, Lo D. Mature microglia resemble immature antigen-presenting cells. Glia 1998;22:72-85.
42. Wahler JB, Swain MG, Carson R, Bergasa NV, Jones EA. Blood-brain barrier permeability is markedly decreased in cholestasis in the rat. HEPATOLOGY 1993;17:1103-1108.
43. Norman MU, Kubes P. Therapeutic intervention in inflammatory diseases: a time and place for anti-adhesion therapy. Microcirculation 2005;12:91-98.
44. Pollak Y, Ovadia H, Orion E, Weidenfeld J, Yirmiya R. The EAE-associated behavioral syndrome: I. Temporal correlation with inflammatory mediators. J Neuroimmunol 2003;137:94-99.
45. Bluthe RM, Laye S, Michaud B, Combe C, Dantzer R, Parnet P. Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice. Eur J Neurosci 2000;12:4447-4456.
46. Warren EJ, Finck BN, Arkins S, Kelley KW, Scamurra RW, Murtaugh MP, et al. Coincidental changes in behavior and plasma cortisol in unrestrained pigs after intracerebroventricular injection of tumor necrosis factor-alpha. Endocrinology 1997;138:2365-2371.
47. Hayley S, Staines W, Merali Z, Anisman H. Time-dependent sensitization of corticotropin-releasing hormone, arginine vasopressin and c-fos immunoreactivity within the mouse brain in response to tumor necrosis factor-alpha. Neuroscience 2001;106:137-148.
48. Watanobe H, Takebe K. Intravenous administration of tumor necrosis factor-alpha stimulates corticotropin releasing hormone secretion in the push-pull cannulated median eminence of freely moving rats. Neuropeptides 1992;22:81-84.
49. Cho L, Tsunoda M, Sharma RP. Effects of endotoxin and tumor necrosis factor alpha on regional brain neurotransmitters in mice. Nat Toxins 1999;7:187-195.